土贝母苷甲通过促进GPX4泛素化降解诱导结直肠癌细胞铁死亡

doi:10.16333/j.1001-6880.2025.3.002

天然产物研究与开发 ›› 2025, Vol. 37 ›› Issue (3): 403-410.doi: 10.16333/j.1001-6880.2025.3.002 cstr: 32307.14.1001-6880.2025.3.002

土贝母苷甲通过促进GPX4泛素化降解诱导结直肠癌细胞铁死亡

王萍1，王长福2，韩士林1，匡海学1，王秋红1,2*

1黑龙江中医药大学教育部北药基础与应用研究重点实验室，哈尔滨 150001；2广东药科大学广东省中药饮片规范化炮制工程技术研究中心，广州510006

出版日期:2025-04-01 发布日期:2025-04-01
基金资助:
国家重点研发计划中医药现代化研究重点专项(2018YFC1707100)；2022 年全国名老中医药专家传承工作室建设项目(2022-75)；黑龙江省教育厅“头雁”团队支持项目(2019-5)

Tubeimoside I induced ferroptosis in colorectal cancer cells by promoting ubiquitinated degradation of GPX4

WANG Ping1,WANG Chang-fu2,HAN Shi-lin1,KUANG Hai-xue1,WANG Qiu-hong1,2*

1Key Laboratory of Basic and Application Research of Beiyao Ministry of Education,Heilongjiang University of Chinese Medicine,Harbin 150040,China; 2Guangdong Standardized Processing Engineering Technology Research Center of Traditional Chinese Medicine,Gaungdong Pharmaceutical Univerisity,Guangzhou 510006,China

Online:2025-04-01 Published:2025-04-01

摘要/Abstract

摘要：

本研究旨在探究土贝母苷甲(tubeimoside I，TBMS 1)诱导的结肠癌细胞HCT116细胞铁死亡及分子机制。体外培养结直肠癌HCT116细胞，MTT法检测不同浓度TBMS 1作用HCT116细胞的存活率，并根据此结果进行分组；克隆形成实验检测TBMS 1对HCT116细胞增殖能力的影响；Western blot法检测细胞中溶质载体家族7成员11(solute carrier family 7 member 11，SLC7A11)和谷胱甘肽过氧化物酶(glutathione peroxidase 4，GPX4)的表达；流式细胞仪及荧光显微镜检测细胞中脂质活性氧(lipid reactive oxygen species，Lipid ROS)水平的变化；丙二醛(malondialdehyde，MDA)、谷胱甘肽(glutathione，GSH)、亚铁离子(Fe²⁺)试剂盒分别检测细胞中MDA，GSH以及Fe²⁺的相对水平；免疫共沉淀法检测GPX4蛋白的泛素化水平。研究结果表明随TBMS 1药物浓度的增加，HCT116细胞的存活率逐渐降低，克隆形成能力逐渐降低；细胞中加入TBMS 1后，GSH水平降低，而Fe²⁺和MDA水平增加；HCT116细胞中加入TBMS 1作用后，细胞中氧化态的Lipid ROS绿色荧光明显增加且Lipid ROS水平明显增加；在细胞中同时加入TBMS 1和铁死亡抑制剂ferrostatin-1(Fer-1)能够逆转TBMS 1导致的细胞死亡，且细胞中加入不同浓度的TBMS 1能够抑制GPX4蛋白的表达，而对SLC7A11蛋白的表达几乎没有影响；与对照组相比，单独加入TBMS 1对GPX4蛋白表达的抑制能够被Fer-1所逆转，且蛋白免疫共沉淀结果显示，TBMS 1促进了GPX4蛋白的泛素化和降解。本研究结果发现TBMS 1可能通过促进GPX4蛋白的泛素化和降解诱导结直肠癌HCT116细胞铁死亡并抑制其恶性增殖。

关键词:

土贝母苷甲, 结直肠癌, 增殖, 谷胱甘肽过氧化物酶4, 铁死亡, 泛素化

Abstract:

This study aims to investigate tubeimoside I (TBMS 1)-induced ferroptosis and molecular mechanism in colorectal cancer HCT116 cells.HCT116 cells were cultured in vitro,and MTT assay was used to detect the survival rate of cells with different concentrations of TBMS 1,and the cells were grouped according to this result.Colone formation assay was used to detect the effect of TBMS 1 on the proliferative ability of HCT116 cells;Western blot assay was used to detect the expression of SLC7A11 and GPX4 in the cells;flow cytometry and fluorescence microscopy were used to detect the changes of lipid reactive oxygen species (Lipid ROS) in the cells;malondialdehyde (MDA),glutathione (GSH),and Fe²⁺ iron kit were used to detect the relative level of MDA,GSH,and Fe²⁺,respectively;and the immunoprecipitation assay was used to detect the ubiquitylation level of the GPX4 protein.Compared with 0 μmol/L TBMS 1,the viability of HCT116 cells gradually decreased with the increase of TBMS 1 concentration,and the clone formation ability gradually decreased,and the GSH level decreased,while the Fe²⁺ and MDA levels increased after treatment by TBMS 1.The green fluorescence of Lipid ROS in the oxidative state and the level of Lipid ROS in the cells were significantly increase after the addition of TBMS 1 to HCT116 cells compared to the effect of 0 μmol/L TBMS 1.Simultaneous addition of TBMS 1 and ferroptosis inhibitor ferrostatin-1 (Fer-1) to the cells was able to reverse the cell death caused by TBMS 1,and the addition of different concentrations of TBMS 1 to the cells was able to inhibit the expression of GPX4 protein,while it had almost no effect on the expression of SLC7A11 protein.The inhibition of GPX4 protein expression by the addition of TBMS 1 alone was able to be reversed by Fer-1 compared to the control group,and protein immunoprecipitation showed that TBMS 1 promoted ubiquitination and degradation of GPX4 protein.TBMS 1 may induce ferroptosis and inhibit malignant proliferation of colorectal cancer HCT116 cells by promoting ubiquitination and degradation of GPX4.

Key words: tubeimoside I, colorectal cancer, proliferation, glutathione peroxidase 4, ferroptosis, ubiquitin

中图分类号: R93

王萍, 王长福, 韩士林, 匡海学, 王秋红. 土贝母苷甲通过促进GPX4泛素化降解诱导结直肠癌细胞铁死亡[J]. 天然产物研究与开发, 2025, 37(3): 403-410.

WANG Ping, WANG Chang-fu, HAN Shi-lin, KUANG Hai-xue, WANG Qiu-hong. Tubeimoside I induced ferroptosis in colorectal cancer cells by promoting ubiquitinated degradation of GPX4[J]. NATURAL PRODUCT RESEARCH AND DEVELOPMENT, 2025, 37(3): 403-410.

[1]	郭亚莉, 刘青, 郭辉, 常景芝. 山柰酚对链脲佐菌素诱导糖尿病肾病大鼠的治疗作用及机制研究[J]. 天然产物研究与开发, 2025, 37(3): 393-402.
[2]	占海兵, 蒋小涵, 李锐, 滕晶晶, 夏新, 杨同金, 王岩, 吴婷. 姜黄素对小鼠肠纤维化的保护作用及机制研究[J]. 天然产物研究与开发, 2025, 37(3): 529-536.
[3]	徐哲, 刘志成, 戴晓宇, 赵莎莎, 戴依辰, 李栋. 烟酰胺单核苷酸与二甲双胍对NK细胞增殖、脆性和杀瘤功能的影响[J]. 天然产物研究与开发, 2024, 36(增刊2): 10-18.
[4]	李振豪, 黎灵, 刘婉榆, 王楠. 天然冰片对宫颈癌细胞生物学行为的调控及机制研究[J]. 天然产物研究与开发, 2024, 36(7): 1191-1199.
[5]	刘玉玲, 陈利荣, 侯艳香, 王元森. 基于网络药理学和细胞实验探讨蟾蜍灵治疗胃癌的作用机制[J]. 天然产物研究与开发, 2024, 36(6): 1045-1055.
[6]	王乐, 芦春斌. 基于体外细胞实验和网络药理学探讨槐定碱治疗前列腺癌的作用机制[J]. 天然产物研究与开发, 2024, 36(3): 528-539.
[7]	林浩, 代伟宏, 刘昌江, 王先薇. 中药单体活性成分抗结直肠癌的研究进展[J]. 天然产物研究与开发, 2023, 35(9): 1637-1649.
[8]	屈雅琴, 张倩玉, 谈相云, 郑国华, 邱振鹏, 田先翔. 荷叶碱抑制Akt/mTOR/4EBP1-糖酵解通路抗胆管癌细胞增殖作用研究[J]. 天然产物研究与开发, 2023, 35(8): 1297-1304.
[9]	刘晓燕, 龙凤, 赵玉, 侯茜, 叶海琳, 周旋, 李雪. 基于PI3K/Akt/GSK-3β通路探讨蒲公英多糖对三阴性乳腺癌细胞迁移和侵袭的影响[J]. 天然产物研究与开发, 2023, 35(7): 1135-1143.
[10]	郑媞, 董欣敏, 张子英, 李华, 白喜玲, 张剑. 木犀草素负向调节核糖体蛋白S12表达抑制MDA-MB-231细胞增殖与侵袭[J]. 天然产物研究与开发, 2023, 35(7): 1198-1205.
[11]	林浩, 代伟宏, 刘昌江, 陈宗军, 严容燕, 王先薇. 基于Hedgehog信号通路的黄芩苷抗炎性结直肠癌的机制研究[J]. 天然产物研究与开发, 2023, 35(5): 741-749.
[12]	周永福, 姚如杰, 黎学明, 杨成威. 民族药四数九里香的化学成分及其细胞毒活性研究（Ⅲ）[J]. 天然产物研究与开发, 2023, 35(4): 622-629.
[13]	杨婷, 张贝贝, 解伟, 王进. 白皮杉醇对子宫内膜癌HEC-1A细胞增殖、迁移和侵袭的影响[J]. 天然产物研究与开发, 2023, 35(3): 489-496.
[14]	陈博文, 陈建平, 黄文浩, 钟赛意, 李瑞, 宋兵兵, 刘晓菲, 汪卓. 岩藻多糖纳米硒的制备及其抑制肿瘤细胞增殖的研究[J]. 天然产物研究与开发, 2023, 35(12): 2117-2126.
[15]	张哲, 王蓓, 唐根云, 饶利兵, 林玲. 基于网络药理学和实验验证探讨海巴戟抗动脉粥样硬化的作用机制[J]. 天然产物研究与开发, 2023, 35(11): 1977-1990.

土贝母苷甲通过促进GPX4泛素化降解诱导结直肠癌细胞铁死亡

Tubeimoside I induced ferroptosis in colorectal cancer cells by promoting ubiquitinated degradation of GPX4

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价